Usefulness of antinuclear antibody testing to screen for rheumatic diseases

Archives of Disease in Childhood

Volumn 77, Issue 4, 1997, Pages 299-304

  Malleson, Peter N ^a,b   Sailer, Michaela ^a   Mackinnon, Murray J ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Antinuclear antibody test; Rheumatic diseases; Systemic lupus erythematosus; Test characteristics

Indexed keywords

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOFLUORESCENCE; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIXED CONNECTIVE TISSUE DISEASE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SCREENING; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030800889     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.77.4.299     Document Type: Article

References (13)

1. Tan EM, Cohen AS, Fries JF, et ai. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum I982;25:1271-7.
2. Haynes DC, Gershwin ME, Robbins DL, Miller JJ1, Cosca D. Autoantibody profiles in juvenile arthritis. J Rheumaiol 1986;13:358-63.
3. Montecucco C, Ravelli A, Caporali R, et a. Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol 1990;8: 193-6.
4. Ferraz MB, Goldenberg J, Hilario MO, et al. Evaluation of the 1982 ARA lupus criteria data set in paediatric patients. Committee of Pédiatrie Rheumatology of the Brazilian Society of Pediatrics. Clin Exp Rheumatol 199-};12:689-90.
5. Cabrai DA, Petty RE, Fung M, Malleson PN. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics 1992;89:441-4.
6. Deane PMG, Liard G, Siegel DM, Baum J. The outcome of children referred to a pédiatrie rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics 1995;95:892-5.
7. McCune WJ, Wise FT, Cassidy JT. A comparison of antinuclear antibody (ANA) tests in children with juvenile rheumatoid arthritis CJRA) on HEp-2 cell and mouse liver (ML) substrates. Association of mitotic figure fluorescence with uveitis. J Rheumata 1986;13:980.
8. Hanky JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Diagnostic Radiology 1982;143:29-36.
9. Chudwin DS, Ammann AJ, Cowan MJ, Wara DW. Significance of a positive antinuclear antibody test in a pédiatrie population. Am J Dis Child 1983;137:1103-6.
10. Arroyave CM, Giarnbrone MJ, Rich KG, Walaszek M. The frequency of antinuclear antibody (ANA) in children by use of mouse kidney (MK) and human epithelial cells (HEp-2) as substrates. JAllergy Gin ImmunoI1988;S2:7. 4.
11. Sulcebe G, Morcka K. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Clin Exp Rheumatal 1992;10:225-61.
12. Slater CA, Shmerling RH. The predictive value of antinuclear antibody (ANA) testing. Arthritis Rheum 1994; 37:5320 (abstr).
13. Malleson PN, Fung MY, Rosenberg AM, for the Canadian Pédiatrie Rheumatology Association. The incidence of pédiatrie rheumatic diseases: results from the Canadian Pédiatrie Rheumatology Association Disease Registry. J Rheumatol 1996;23:1981-7.